ABSTRACT
Cardiovascular medicine is one of the most resource-consuming parts of the healthcare system and many examples of overdiagnostic and overtreatment can be found. The present article presents just three of these, one from cardiology and two from vascular medicine. The topic of chronic coronary heart disease concerns the unequivocal proof of ischemia before a coronary intervention. The sections on Duplex sonography of the cervical blood vessels and the diagnostics of thrombophilia describe which valid clinical problems may justify the performance of these examinations at all. The potential for harm caused by overdiagnostics in both cases lies not only in the unnecessary use of resources but, more importantly, in the subsequent overtreatment. The few appropriate indications are described in detail.
Subject(s)
Cardiology , HumansABSTRACT
Background: Thrombosis is a common complication of cancer with a negative impact on quality of life and overall prognosis. Guidelines recommend low-molecular-weight heparin (LMWH) as initial and prolonged anticoagulation treatment. Little is known about current treatment patterns of these patients in ambulatory care. Patients and methods: The current retrospective observational study interrogates a large German statutory health insurance claims database in order to understand which kind of data can be extracted and analysed. An age- and sex-adjusted sample of about 4.1 million insured people from 2011 to 2016 could be used. Cancer patients with incident deep and superficial leg vein thrombosis were identified. Patients with preexisting cancer were allocated to a normal risk group; those who suffered from simultaneously diagnosed cancer and thrombosis were classified as high-risk group. Results: We identified 322,600 patients with inpatient or outpatient documented cancer diagnosis in at least two different quarters within one year. 87,755 patients were identified with an incident deep or superficial vein thrombosis. 8,201 patients suffered from both cancer and incident thrombosis. 56.9% of the patients received an anticoagulation regimen with predominant LMWH prescription, 24.2% vitamin K antagonists, 17.2% direct oral anticoagulants; in 1.7% of patients, no predominant anticoagulant drug/regime could be identified. On average, patients were prescribed anticoagulants for 4.5 months. An estimate of clinically relevant gastrointestinal bleeding could be derived (1.8% of patients). Conclusions: The dataset allows assigning detailed information of anticoagulant prescriptions in ambulatory care to well-defined groups of cancer patients. A first analysis suggests that in Germany current medical care of patients with cancer-related deep or superficial vein thrombosis does not entirely comply with guideline recommendations regarding type and duration of anticoagulation.
Subject(s)
Anticoagulants/therapeutic use , Thrombosis , Germany , Heparin, Low-Molecular-Weight , Humans , Insurance, Health , Leg , Quality of Life , Retrospective Studies , Thrombosis/drug therapySubject(s)
Anticoagulants/therapeutic use , Antiphospholipid Syndrome/drug therapy , Factor Xa Inhibitors/therapeutic use , Rivaroxaban/therapeutic use , Vitamin K/antagonists & inhibitors , Warfarin/therapeutic use , Administration, Oral , Antibodies, Antiphospholipid/blood , Anticoagulants/administration & dosage , Antiphospholipid Syndrome/blood , Antiphospholipid Syndrome/complications , Factor Xa Inhibitors/administration & dosage , Humans , Lupus Coagulation Inhibitor/blood , Meta-Analysis as Topic , Prospective Studies , Randomized Controlled Trials as Topic , Rivaroxaban/administration & dosage , Thromboembolism/etiology , Warfarin/administration & dosage , beta 2-Glycoprotein I/bloodABSTRACT
Proximal femoral fractures are urgent indications for surgery. In cases of delayed surgical treatment more than 48â¯h after hospital admittance, increased rates of general complications, local complications and mortality have been proven. Since 2015, the quality target for the external quality assurance by order of the Federal Joint Committee (G-BA) is surgical treatment within 24â¯h after hospital admittance for osteosynthesis and within 48â¯h for joint replacement. The foundations for these time intervals are the S2e guidelines for the treatment of femoral neck fractures of adults from the German Society of Trauma Surgery (DGU) and the Austrian Society of Trauma Surgery (ÖGU) and several other international guidelines. The distinction of the temporal specifications between osteosynthesis and joint replacement in Germany is unusual in comparison with other countries. For 15% of each group of patients a prolonged preoperative preparation is accepted. In the structured dialog within the external quality management anticoagulants are quoted as the most frequent reason for delayed surgery. The present review provides a way to achieve compliance with statutory provisions, to minimize the risks of both bleeding and thromboembolism and to achieve surgical treatment of proximal femoral fractures within the agreed time limit.
Subject(s)
Femoral Fractures , Anticoagulants , Austria , Fracture Fixation, Internal , Germany , HumansABSTRACT
Approximately 30% of patients receiving oral anticoagulation using vitamin K antagonists (VKA) require surgery within 2 years. In this context, a clinical decision on the need and the mode of a peri-interventional bridging with heparin is needed. While a few years ago, bridging was almost considered a standard of care, recent study results triggered a discussion on which patients will need bridging at all. Revisiting the currently available recommendations and study results the conclusion can be drawn that the indications for bridging with heparin must nowadays be taken more narrowly and considering the individual patient risk of bleeding and thromboembolism. Bridging with heparin is only needed in patients with a very high risk of thromboembolism. This overview aims to give guidance for a risk-adapted peri-interventional approach to management of patients with a need for long-term anticoagulation using VKA.
Subject(s)
Anticoagulants , Thromboembolism , Vitamin K , Administration, Oral , Anticoagulants/therapeutic use , Humans , Perioperative Care , Thromboembolism/prevention & control , Vitamin K/antagonists & inhibitorsABSTRACT
Approximately 30% of patients receiving oral anticoagulation using vitamin K antagonists (VKA) require surgery within 2 years. In this context, a clinical decision on the need and the mode of a peri-interventional bridging with heparin is needed. While a few years ago, bridging was almost considered a standard of care, recent study results triggered a discussion on which patients will need bridging at all. Revisiting the currently available recommendations and study results the conclusion can be drawn that the indications for bridging with heparin must nowadays be taken more narrowly and considering the individual patient risk of bleeding and thromboembolism. Bridging with heparin is only needed in patients with a very high risk of thromboembolism. This overview aims to give guidance for a risk-adapted peri-interventional approach to management of patients with a need for long-term anticoagulation using VKA.
Subject(s)
Anticoagulants/therapeutic use , Fibrinolytic Agents/therapeutic use , Heparin/therapeutic use , Vitamin K/antagonists & inhibitors , Blood Coagulation/drug effects , Hemorrhage/chemically induced , Humans , Thrombolytic Therapy/methodsABSTRACT
In outpatient care or the emergency room laboratory tests oftentimes provide the first clues to the medical condition that made the patient seek medical help. Quite commonly, rapid medical decisions are required in these situations. Therefore, laboratory results must be evaluated immediately and interpreted within the broader context of the patient's presentation. During this process test results must be checked for plausibility, their positive and/or negative predictive values for the individual patient must be considered, and finally, the potential clinical implications need to be assessed. The latter in particular is of the utmost importance. This article discusses several laboratory tests commonly ordered for emergency patients and provides some guidance on their relevance in the decision to refer an outpatient to an emergency room or for inpatient care, or whether a patient can be safely diagnosed in the outpatient setting.
Subject(s)
Acute Disease , Clinical Laboratory Techniques/standards , Emergency Medical Services , Blood Cell Count , Blood Chemical Analysis , Blood Coagulation Tests , Clinical Laboratory Techniques/statistics & numerical data , Diagnosis, Differential , Emergency Service, Hospital , Humans , Predictive Value of Tests , Referral and Consultation , Reproducibility of ResultsABSTRACT
Symptoms of the leg or of both legs, may indicate a need for evaluation and/or treatment, which must be clarified urgently or even as an emergency situation. Among the diseases which must be considered from a vascular viewpoint are critical limb ischemia, suspicion of deep leg vein thrombosis and special forms of venous insufficiency. With respect to infections erysipelas and the syndrome of infected diabetic foot must be considered as well as peripheral and central leg paresis as orthopedic and neurological disorders, respectively. The current review summarizes the main clinical features of these diseases. Criteria are discussed as to which require the particular capabilities of a hospital and which patients can be managed in an outpatient setting.
Subject(s)
Ambulatory Care , Emergency Medical Services , Leg , Cellulitis/diagnosis , Diabetic Foot/diagnosis , Erysipelas/diagnosis , Humans , Interdisciplinary Communication , Intersectoral Collaboration , Ischemia/diagnosis , Leg/blood supply , Leg Ulcer/diagnosis , Paresis/diagnosis , Venous Thrombosis/diagnosisABSTRACT
Visceral vessel processes are primarily or secondarily included in a multitude of clinical abdominal symptoms, with which the specialist in internal medicine is confronted. The spectrum ranges from more sharply outlined manifestations, such as chronic ischemic bowel disease up to dysfunctional disturbances of blood pressure regulation, such as high-grade renal artery stenosis. Sometimes diseases with prognostic implications, such as arterial aneurysms, are revealed as incidental findings. As a rule the Bmode and duplex ultrasound can often be complemented by computed tomography (CT) and magnetic resonance imaging (MRI), as in aneurysms or portal vein thrombosis or the indications for subsequent digital subtraction angiography (DSA) and catheter-based therapy can be directly obtained from duplex and Doppler ultrasound. The present review article focuses on the use of these methods in the most important diseases, with the exception of acute abdomen because this requires further detailed etiological and diagnostic systematization.
Subject(s)
Abdomen/blood supply , Intestines/blood supply , Abdomen/diagnostic imaging , Aneurysm/diagnostic imaging , Angiography, Digital Subtraction , Humans , Incidental Findings , Intestines/diagnostic imaging , Ischemia/diagnostic imaging , Magnetic Resonance Imaging , Tomography, X-Ray Computed , Ultrasonography , Ultrasonography, Doppler, DuplexABSTRACT
Depending on the type and acuteness, diseases of the aorta can be imaged by a variety of techniques. Modalities and quality of imaging have developed rapidly in recent years. In combination with the clinical assessment of patients, the results obtained by imaging determine the further management. They not only establish the underlying diagnosis but provide the information essential for indications, planning and reassessment of therapy, as well as for evaluation of the clinical course and surveillance. Whereas conventional catheter-guided angiography and intravascular ultrasound are only used in exceptional cases and then in conjunction with interventional therapy, cross-sectional imaging modalities, such as contrast-enhanced computed tomography (CT) angiography and magnetic resonance imaging (MRI) are nowadays the mainstay of diagnostics. Ultrasound techniques are improving steadily and are gaining increasing importance, e. g. for screening purposes and for pretherapeutic and posttherapeutic surveillance. Additional information of therapeutic relevance may be acquired by means of molecular imaging with positron emission tomography (PET) CT.
Subject(s)
Aorta/diagnostic imaging , Aortic Diseases/diagnostic imaging , Aortic Diseases/therapy , Aortography , Contrast Media , Humans , Magnetic Resonance Imaging , Tomography, X-Ray Computed , UltrasonographySubject(s)
Cardiology/trends , Ultrasonography, Doppler, Duplex/trends , Vascular Diseases/diagnostic imaging , Cardiology/economics , Contract Services/economics , Contract Services/trends , Cost-Benefit Analysis/economics , Cost-Benefit Analysis/trends , False Positive Reactions , Forecasting , Germany , Humans , Mass Screening/economics , Mass Screening/trends , Medical Overuse/economics , Medical Overuse/trends , Ultrasonography, Doppler, Duplex/economics , Vascular Diseases/economics , Vascular Diseases/etiologyABSTRACT
Several techniques are available for imaging of the venous system of the legs and pelvic region. In cases of suspected deep leg vein thrombosis Bmode compression ultrasound is applied. Its accuracy is sufficient to either confirm or exclude the diagnosis with certainty. For examination of the iliac veins, however, flow information has to be added by pulsed wave (PW) Doppler or color Doppler sonography. In cases of suspected arm vein thrombosis, ultrasound is also the method of choice. The more proximal or the central parts of the venous system, i. e. brachiocephalic veins or the superior and inferior vena cava can be visualized by cross-sectional imaging procedures. Computed tomography (CT) angiography accurately shows the vessel lumen and magnetic resonance imaging (MRI) provides more details of the surrounding soft tissue. The use of classical contrast medium phlebography is nowadays restricted to interventions on proximal or central parts of the venous system. In addition, venous imaging is required in the field of chronic venous insufficiency. For both differential diagnostics and choice of treatment options, e. g. for varicose veins, the mainstay is venous ultrasound.
Subject(s)
Arm/blood supply , Iliac Vein/diagnostic imaging , Leg/blood supply , Pelvis/blood supply , Veins/diagnostic imaging , Venous Thrombosis/diagnostic imaging , Arm/diagnostic imaging , Humans , Leg/diagnostic imaging , Pelvis/diagnostic imaging , Phlebography , Tomography, X-Ray Computed , Ultrasonography , Varicose Veins/diagnostic imagingABSTRACT
Nowadays, several technically validated modalities are available for imaging both the extracranial and intracranial segments of arteries supplying blood to the brain. In the acute stroke setting, computed tomography (CT) angiography is of utmost importance because it provides the key diagnostic criteria indicative for the use of catheter-based recanalization techniques. Ultrasound imaging of extracranial arteries is most suitable for detecting an underlying stenosis of the internal carotid artery (ICA) in patients with stroke, transient ischemic attacks (TIA), retinal vessel occlusion and amaurosis fugax. Ultrasound imaging enables measurement of the methodologically most reliable criteria for grading stenosis of the ICA, which defines the indications for revascularization procedures in this territory. Magnetic resonance imaging (MRI) in the cross-sectional mode is of greatest value in confirming or excluding an arterial dissection even in short arterial segments, whereas MR angiography generates a more global view of the cerebral circulation. In most cases classical digital subtraction angiography (DSA) is no longer needed for diagnostic purposes only. Conversely, it is an indispensable component of any interventional approach and thus of growing importance. Ultrasound imaging is not indicated for the clarification of vertigo or syncope. In addition, there is no evidence that ultrasound screening of the ICA adds any value to the care of asymptomatic persons.
Subject(s)
Brain/blood supply , Cerebral Arteries/diagnostic imaging , Stroke/diagnostic imaging , Angiography, Digital Subtraction , Brain/diagnostic imaging , Carotid Stenosis/diagnostic imaging , Cerebral Angiography/methods , Cross-Sectional Studies , Humans , Magnetic Resonance Imaging , Tomography, X-Ray Computed , UltrasonographyABSTRACT
Essentials Protamine (PRT) is used to stabilize insulin in neutral protamine Hagedorn (NPH) insulin. The interaction between NPH-insulin, anti-PRT/heparin antibodies and platelets was investigated. Anti-PRT/heparin antibodies activate platelets in presence of NPH-insulin dependent on heparin. Cross-reactivity seems to have no major effect on the clinical outcome of medical patients. SUMMARY: Background Protamine (PRT) is used to stabilize insulin in neutral protamine Hagedorn (NPH) insulin, a commonly used therapeutic agent for diabetes mellitus. Immunization against PRT/heparin complexes is common in diabetic patients. Objectives To investigate the impact of NPH-insulin on the interaction between anti-PRT/heparin antibodies and platelets. Methods The interaction between NPH-insulin and anti-PRT/heparin antibodies was tested using in-house enzyme immunoassays. The ability of anti-PRT/heparin antibodies to activate platelets in the presence of NPH-insulin (and heparin) was investigated using flow cytometry. Results Twenty-one out of 80 sera containing anti-PRT/heparin IgG showed binding to NPH-insulin. Anti-PRT/heparin IgG from immunized patients bound to platelets in the presence of NPH-insulin, but not in the presence of native insulin. Anti-PRT/heparin antibodies induced P-selectin expression in the presence of NPH-insulin in a heparin-dependent way (median mean fluorescence intensity in the presence of NPH-insulin: 55, 95% confidence interval [CI] 18.7-100.5 vs. NPH-insulin and heparin: 204, 95% CI 106.5-372.8). The clinical relevance of platelet-activating anti-PRT/heparin antibodies was assessed by investigating a multicenter study cohort of 332 acutely ill medical patients who received heparin. None of the 21 patients with anti-PRT/heparin IgG developed thrombocytopenia or thromboembolic complications. Conclusions Anti-PRT/heparin antibodies activate platelets in the presence of NPH-insulin in a heparin-dependent way. However, results from our preliminary study indicate no major impact of these antibodies on the clinical outcome in medical patients receiving heparin, particularly on thromboembolic complications.
Subject(s)
Antibodies/chemistry , Heparin/chemistry , Insulin, Isophane/chemistry , Platelet Activation , Protamines/chemistry , Aged , Anticoagulants/chemistry , Blood Platelets/metabolism , Diabetes Mellitus/drug therapy , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Humans , Immunoassay , Inpatients , Insulin/chemistry , Male , P-Selectin/metabolismABSTRACT
The diagnostic pathway for the evaluation of patients with dyspnea requires a thorough history taking and physical examination. Based on the results of these basic steps a broad variety of additional diagnostic tests are available. Each test can contribute valuable information when correctly indicated and performed. Among these are electrocardiography (ECG), laboratory parameters, X-ray examination, echocardiography, spirometry and whole body plethysmography and finally spiroergometry. This article presents a focused review of what each of these diagnostic modalities can contribute to the diagnostic process for dyspnea.